hGH Fragment 176-191 6mg

hGH Fragment 176-191 6mg — Targeted Lipolytic Peptide Research Formulation

hGH Fragment 176-191 is a modified, synthetic C-terminal fragment of human growth hormone (amino acids 176–191). This specialized 6mg lyophilized presentation is specifically designed for researchers investigating lipid metabolism, lipolysis acceleration, and adipocyte signaling without impacting blood glucose levels or insulin sensitivity.

• Purity & Precision Guaranteed: Synthesized to a baseline purity of $\ge 99\%$ verified by rigorous HPLC and Mass Spectrometry testing, keeping your laboratory assays consistent with strict standards on the Peptide Sciences Official platform.

• Targeted Lipolytic Mechanism: Meticulously isolated to replicate the specific lipolytic actions of intact growth hormone, effectively stimulating fat breakdown (lipolysis) and inhibiting lipogenesis while avoiding growth-promoting or glycemic effects.

• Key Research Fields: Highly utilized in metabolic biology, endocrinology, and obesity research models to analyze adipose tissue reduction, cellular lipid oxidation pathways, and metabolic rate modulation.

• Lyophilized Stability Baseline: Supplied in a sterile, freeze-dried powder format to safeguard the short peptide chain from premature environmental degradation, ensuring accurate reconstitution parameters.

Research Compliance & Sourcing Notice: This product is sold strictly as a high-purity research chemical. It is intended solely for laboratory, in vitro, or animal research applications and is not approved for human consumption, therapeutic, or diagnostic use. For verified, high-quality reference standards and compliant distribution channels, researchers rely on authorized supply pathways like Official Peptide Partners.